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ABSTRACT 
OBJECTIVE: To describe the epidemiology of health-
care-associated infections (HAIs) among neonates. 
DESIGN: Prospective surveillance of HAIs was conduct-
ed during 2 years. Infections beginning within 48 hours of birth 
were defined as HAIs of maternal origin. Death occurring during 
an active episode of HAI was considered related to HAL 
SETTING: Seven neonatal units located in three Brazilian 
cities. 
PATIENTS: All admitted neonates were included and 
observed until discharge. 
RESULTS: Twenty-two percent of 4,878 neonates had at 
least one HAI. The overall incidence density was 24.9 per 1,000 
patient-days, and 28.1% of all HAIs were maternally acquired. HAI 
rates ranged from 12.3% in the group with a birth weight (BW) of 
more than 2,500 g to 51.9% in the group with a BW of 1,000 g or 
less. The main HAIs were bloodstream infection (BSI) and pneu-
monia. Coagulase-negative staphylococci, Enterobacter species, 
Staphylococcus aureus, and Klebsiella pneumoniae were the main 
pathogens. Forty percent of all deaths were related to HAI. 
Central venous catheter (CVC)-associated BSIs per 1,000 CVC-
days ranged from 17.3 (BW, 1,501 to 2,500 g; device utilization 
[DU], 0.11) to 34.9 (BW, =s 1,000 g; DU, 34.92). Ventilator-associ-
ated pneumonia per 1,000 ventilator-days ranged from 7.0 (BW, =s 
1,000 g; DU, 0.34) to 9.2 (BW, 1,001 to 1,500 g; DU, 0.14). 
CONCLUSIONS: The high proportion of HAIs of mater-
nal origin highlights perinatal care issues in Brazil and the need 
to improve the diagnosis of neonatal HAIs. The very low BW 
group and device-associated infections should be priorities for 
prevention strategies in this population {Infect Control Hosp 
Epidemiol 2004;25:772-777). 
The intensive use of medical devices for and the 
immaturity of the immunologic system of neonates admit-
ted to neonatal units increase their risk of developing 
healthcare-associated infections.1 Nosocomial infections 
affect up to 30% of neonates,26 and rates can be more than 
5 times higher in this population compared with older 
children.34 A better understanding of the epidemiology of 
neonatal healthcare-associated infections may lead to 
prevention strategies in neonatal units and therefore 
reduced morbidity and mortality related to these infec-
tions. 
In Brazil, 60% of deaths among children in their first 
year occur during the neonatal period. However, the rate 
of healthcare-associated infections and the proportion of 
deaths related to these infections are unknown. This arti-
cle describes the epidemiology of healthcare-associated 
infections among neonates in seven neonatal units located 
in three Brazilian cities. 
M E T H O D S 
Setting and Design 
Prospective surveillance of healthcare-associated 
infections in seven neonatal units was conducted from 
January 1, 1997, to December 31, 1998. The units were 
located in the cities of Rio de Janeiro, Campinas, and 
Sao Paulo, and the number of beds ranged from 5 to 55. 
All units had conveniently located sinks with paper tow-
els, and handwashing with an antiseptic soap (2% 
chlorhexidine gluconate) was the standard procedure 
for hand hygiene. The ratio of nursing staff to neonates 
ranged from 1:1 to 1:3 for intensive care and 1:2 to 1:4 
for intermediate care. All neonates admitted to the 
neonatal units for more than 24 hours were included in 
the study and were observed until discharge. Routine 
infection control measures in these units included active 
surveillance of healthcare-associated infections, advice 
on the management of infections, and regular training of 
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TABLE 1 
HEALTHCARE-ASSOCIATED INFECTION RATES ACCORDING TO BIRTH WEIGHT FOR SEVEN NEONATAL UNITS IN BRAZIL DURING 1997 TO 
1998 
Birth Weight (g) 
No. of patients 
No. of patient-days 
No. ofHAIs 
(maternal/hospital origin) 
No. of patients with HAI (%) 
HAI cumulative incidence rate 
HAI incidence density rate 
s 1,000 
395 
10,866 
327 
(70/257) 
205 (51.9) 
82.8 
30.1 
1,001 to 1,500 
639 
15,936 
364 
(69/295) 
264 (41.3) 
57.0 
22.8 
1,501 to 2,500 
1,725 
19,093 
455 
(153/302) 
342 (19.8) 
26.4 
23.8 
> 2,500 
2,119 
14,153 
348 
(128/220) 
261 (12.3) 
16.4 
24.6 
Total 
4,878 
60,048 
1,494 
(420/1,074) 
1,072 (22.0) 
30.6 
24.9 
HAI - healthcare-associated infection. 
personnel regarding standard, hospital infection control 
practices. Active surveillance was conducted by mem-
bers of the hospital infection control team (Rio de 
Janeiro: CLP-S, RMRS, and ACCF; Campinas: RC; and 
Sao Paulo: RR and MLMC), who visited each unit at 
least three times a week and could always be reached 
(even on weekends) by cellular phones and pagers. 
These members were in close contact with unit staff. 
Healthcare-associated infections were identified 
through chart review, participation in ward rounds, and 
review of laboratory reports. 
Definitions and Data Collected 
For surveillance of healthcare-associated infections, 
we employed standard methods for surveillance and defi-
nitions from the high-risk nursery component of the 
National Nosocomial Infections Surveillance System.7,8 All 
infections, except those known or proved to have been 
acquired transplacentally (ie, herpes simplex, toxoplasmo-
sis, rubella, cytomegalovirus, and syphilis), were consid-
ered to be healthcare associated. They were classified into 
two categories: infections occurring up to 48 hours after 
birth were considered healthcare-associated infections of 
maternal origin and those occurring /after this point were 
considered healthcare-associated infections of hospital ori-
gin.9 A device-associated infection was defined as an infec-
tion in a neonatal patient with a device (ie, ventilator or 
central venous catheter [CVC]) that was used within 48 
hours before the onset of the infection.10 If either signs or 
evidence of incubation of infection was already present 
when a device was inserted, the infection was not consid-
ered to be associated with the device. Death was consid-
ered related to healthcare-associated infection if it 
occurred during an active episode of infection. Data col-
lected included number of patients in the neonatal unit, 
total number of patient-days, and device utilization in each 
of the four birth weight groups (group 1, 1,000 g or less; 
group 2, 1,001 to 1,500 g; group 3, 1,501 to 2,500 g; and 
group 4, more than 2,500 g). 
Microbiologic Methods 
Specimens for culture were collected based on clin-
ical criteria established by the medical staff. Blood sam-
ples were drawn through peripheral veins or arteries, 
inoculated onto Bactec-Plus (Becton Dickinson, Franklin 
Lakes, NJ) pediatric medium, and incubated for 120 
hours. Clinical isolates were identified using the VTTEK 
GNI card (VTTEK system, bioMerieux, Inc., Hazelwood, 
MO). An isolate was defined as a healthcare-associated 
infection pathogen if isolated from a sterile fluid (ie, 
blood, urine, cerebrospinal fluid, bronchoalveolar lavage 
with quantitative culture, or fluid or tissue aseptically 
obtained from a surgical incision) of a neonatal patient 
with signs of infection, as previously defined.8 
Rates, Ratios, and Statistical Procedures 
The overall incidence density rate for healthcare-
associated infection was calculated by dividing the num-
ber of healthcare-associated infections by the total num-
ber of patient-days in the neonatal unit during the same 
period and then multiplying by 1,000. The overall cumula-
tive incidence rate for healthcare-associated infection was 
calculated by dividing the number of healthcare-associat-
ed infections by the total number of admitted patients in 
the neonatal unit during the same period and then multi-
plying by 100. We calculated device-associated infection 
rates by dividing the number of cases of pneumonia or pri-
mary bloodstream infection (BSI) by the total number of 
respective device-days and then multiplying by 1,000. The 
device utilization ratios for CVCs and ventilators were cal-
culated by dividing the number of days of device use by 
the number of patient-days. All rates and ratios were strat-
ified according to the four birth weight groups. Statistical 
analyses were performed using chi-square or Fisher's 
exact test, where appropriate. 
RESULTS 
From January 1, 1997, to December 31, 1998, 1,494 
healthcare-associated infections were detected among 
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TABLE 2 
DISTRIBUTION OF 
Site 
SITES OF INFECTION ACCORDING TO BIRTH WEIGHT 
€ 1,000 (%) 
Birth 
1,001 to 1,500 (%) 
FOR SEVEN NEONATAL UNITS 
Weight (g) 
1,501 to 2,500 (%) 
IN BRAZIL DURING 
> 2,500 
1997 TO 1998 
Total (%) 
BSI 
Maternal origin 
Hospital origin 
Pneumonia 
Maternal origin 
Hospital origin 
Eye, ear, nose, and throat 
Conjunctivitis 
Oral 
Other 
Skin and soft tissue 
Skin 
Other 
Gastrointestinal 
Necrotizing enterocolitis* 
Gastroenteritis 
Intra-abdominal 
Central nervous system* 
Surgical-site infection 
Urinary tract infection 
Cardiovascular system 
Othert 
Total 
206 (63.0) 
58 
148 
41 (12.5) 
12 
29 
38 (11.6) 
21 
16 
1 
17 (5.1) 
17 
0 
14 (4.3) 
13 
0 
1 
5 (1.5) 
0(0) 
2 (0.6) 
3 (0.9) 
1 (0.3) 
327 (100) 
177 (48.6) 
59 
118 
34 (9.3) 
9 
25 
61 (9.3) 
29 
29 
3 
37 (10.1) 
36 
1 
30 (8.2) 
18 
12 
0 
10 (2.7) 
7 (1.9) 
3 (0.8) 
5 (1.4) 
0(0) 
364 (100) 
229 (50.3) 
105 
124 
71 (15.6) 
45 
26 
60 (15.6) 
32 
27 
1 
32 (7.0) 
32 
0 
30 (6.6) 
18 
10 
2 
7 (1.5) 
8 (1.8) 
5 (1.1) 
9 (2.0) 
4 (0.9) 
455 (100) 
142 (40.8) 
74 
68 
75 (21.6) 
51 
24 
46 (21.6) 
20 
26 
0 
26 (7.5) 
23 
3 
12 (3.5) 
8 
2 
2 
11 (3.2) 
16 (4.6) 
14 (4.0) 
6(1.7) 
0(0) 
348 (100) 
754 (50.5) 
296 
458 
221 (14.8) 
117 
104 
205 (13.7) 
102 
98 
5 
112 (7.5) 
108 
4 
86 (5.8) 
57 
24 
5 
33 (2.2) 
31 2.1) 
24 (1.6) 
23 (1.5) 
5 (0.3) 
1,494 (100) 
BSI - bloodstream infection. 
*Three cases of necrotizing enterocolitis, four cases of meningitis, and one case of disseminated infection were maternally acquired. 
Three cases of disseminated infection, one case of arthritis, and one case of tracheobronchitis. 
4,878 neonates. Of these neonates, 1,072 (22%) had at 
least one healthcare-associated infection (Table 1). The 
percentage of patients affected by at least one healthcare-
associated infection ranged from 12.3% in group 4 to 51.9% 
in group 1 (P < .001). The overall incidence density was 
24.9 healthcare-associated infections per 1,000 patient-
days, and group 1 had higher rates than did the other 
groups (P < .001). Cumulative incidence rates ranged 
from 16.4 to 82.8 per 100 discharges, being higher among 
groups 1 and 2 (P < .001). Almost 40% (106 of 266) of all 
deaths were related to healthcare-associated infection, 
although this relationship was more prominent among 
neonates of group 2 (21 of 35; 60.0%) than among the 
other groups of neonates (85 of 231; 36.8%) (P= .009). 
Sites of Infection 
The most frequent healthcare-associated infection 
in all birth weight groups was BSI, comprising 50.5% (754 
of 1,494) of all healthcare-associated infections (Table 2). 
BSI was more frequent among very low birth weight 
neonates (< 1,500 g; 14.3 BSIs per 1,000 patient-days) than 
among neonates weighing more (11.2 BSIs per 1,000 
patient-days) (P< .001). Only 13.2% (39 of 296) of the BSIs 
of maternal origin were laboratory confirmed, compared 
with 50% (229 of 458) of the BSIs of hospital origin (P < 
.001). In all BSIs of maternal origin, signs of infection 
were already present or infection was in incubation when 
a CVC was inserted; therefore, they were not considered 
to be associated with the device. On the other hand, 47.8% 
(219 of 458) of the BSIs of hospital origin were associated 
with a CVC, and laboratory confirmation was more fre-
quent when this device was in place: 60.3% (132 of 219) in 
the presence of a CVC versus 40.6% (97 of 239) otherwise 
(P<.001). 
Pneumonia was the second most common health-
care-associated infection, accounting for 14.8% (221 of 
1,494) of all healthcare-associated infections, and was 
more frequent among neonates of groups 3 and 4 (4.4 
cases of pneumonia per 1,000 patient-days) than among 
very low birth weight neonates (2.8 per 1,000 patient-
days) (P < .001). Although ventilator-associated pneumo-
nia comprised most (80%) of the pneumonia of hospital 
origin, the proportion of pneumonia (21 of 104) not asso-
ciated with such a device 48 hours after birth was 
nonetheless substantial. 
Eye, ear, nose, and throat infections were third, fol-
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TABLE 3 
DISTRIBUTION OF HEALTHCARE-ASSOCIATED MICROORGANISMS ISOLATED FROM STERILE FLUIDS* ACCORDING TO SITE OF INFECTION AND 
TIME AFTER BIRTH FOR SEVEN NEONATAL UNITS IN BRAZIL DURING 1997 TO 1998 
Microorganism 
Coagulase-negative staphylococci 
Enterobacter species 
Staphylococcus aureus 
Klebsiella species* 
Group B Streptococcus agalactiae 
Candida species 
Escherichia coli 
Enterococcus faecalis 
Acinetobacter species 
Pseudomonas species* 
Listeria monocytogenes 
Other nonfermentative gram-negative bacilli 
Other enteric bacilli 
Other Streptococcus species 
Others^ 
Total 
BSI 
48 h 
5 
1 
0 
2 
20 
0 
5 
3 
0 
0 
3 
1 
0 
0 
0 
40 
> 48 h 
54 
52 
39 
24 
5 
16 
8 
9 
11 
8 
1 
14 
5 
2 
1 
249 
Other Sites 
48 h > 
0 
0 
0 
0 
0 
1 
1 
1 
0 
0 
0 
0 
1 
1 
1 
6 
48 h 
35 
7 
17 
15 
0 
5 
5 
1 
0 
3 
0 
12 
10 
4 
1 
115 
Tota 
94 
60 
56 
41 
25 
22 
19 
14 
11 
11 
4 
27 
16 
7 
3 
410 
BSI = bloodstream infection. 
*Blood, urine, cerebrospinal fluid, bronchoalveolar lavage with quantitative culture, and fluid or tissue aseptically obtained from a surgical incision. 
tForty K. pneumoniae and 1K. oxytoca. 
*Ten F aeruginosa and 1 Pseudomonas species. 
sOne Haemophilus influenzae, 1 Bacillus species, and 1 Rhodotorula species. 
lowed by skin and soft tissue and gastrointestinal infec-
tions. Conjunctivitis was the most prevalent eye, ear, nose, 
and throat infection. Necrotizing enterocolitis accounted 
for 66.3% of the gastrointestinal infections and it was even 
more prevalent among low birth weight neonates (birth 
weight, < 2,500 g). Mucocutaneous candidiasis was a com-
mon infection in all groups, and oral thrush together with 
cutaneous candidiasis comprised 10.8% of all healthcare-
associated infections. 
Healthcare-Associated Infections of Maternal 
Origin 
A large proportion of all healthcare-associated 
infections (420 of 1,494; 28.1%) began within 48 hours 
after birth, and BSI and pneumonia accounted for 98.3% of 
these infections. As many as 39.3% (296 of 754) of all BSIs 
and 52.9% (117 of 221) of all cases of pneumonia were 
maternally acquired. Interestingly, the proportion of 
healthcare-associated infections of maternal origin was 
much higher among neonates weighing more than 1,500 
g at birth (281 of 803; 35%) than among very low birth 
weight neonates (140 of 691; 20.3%) (P< .001). 
Pathogen Distribution 
Microbiologic identification was possible for only 
389 (26%) of the healthcare-associated infections (268 
BSIs and 121 healthcare-associated infections other than 
BSI). Twenty BSIs were polymicrobial: 19 with two 
pathogens and 1 with three pathogens. A higher propor-
tion of healthcare-associated infections of hospital origin 
(344 of 1,074) had microbiologic identification as com-
pared with those of maternal origin (45 of 420) (P < .0001). 
Microorganisms isolated from sterile fluids are listed in 
Table 3. The five main groups of pathogens were coagu-
lase-negative staphylococci (22.9%), Enterobacter species 
(14.6%), Staphylococcus aureus (13.7%), Klebsiella species 
(10.0%), and group B Streptococcus (6.1%). Gram-positive 
pathogens predominated, with coagulase-negative staphy-
lococci as the leading microorganisms. During the study 
period there was an outbreak of extended-spectrum beta-
lactamase-producing K. pneumoniae in one neonatal 
unit,11 contributing to 15 of the 41 cases of Klebsiella 
species infections. Group B Streptococcus accounted for 
43.5% (20 of 46) of the causative agents of maternal origin, 
followed by Escherichia coli (6 of 46; 13.0%), coagulase-
negative staphylococci (5 of 46; 10.9%), and Enterococcus 
faecalis (4 of 46; 8.7%). 
Device-Associated Infection Rates 
A device was already in place before the incubation 
and the initiation of symptoms in all infections associated 
with a device, and all of these infections occurred 48 
hours after birth. The distributions of device-associated 
infection rates and device utilization ratios are listed in 
Tables 4 and 5. Higher rates of CVC-associated BSI were 
observed in group 1 (P< .001). These neonates also had a 
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TABLE 4 
CENTRAL VENOUS CATHETER (CVC) UTILIZATION RATIO AND 
CVC-ASSOCIATED BLOODSTREAM INFECTION RATE ACCORDING TO 
BIRTH WEIGHT FOR SEVEN NEONATAL UNITS IN BRAZIL DURING 
1997 TO 1998 
Birth 
Weight (g) 
No. of 
Patient-
Days 
No. of 
CVC-Days 
DU 
Ratio* 
CVC-
Assoclated 
BSI Rate* 
=s 1,000 
1,001 to 1,500 
1,501 to 2,500 
> 2,500 
10,866 
15,936 
19,093 
14,153 
2,663 
1,909 
2,136 
1,927 
0.25 
0.12 
0.11 
0.14 
34.92 
20.43 
17.32 
18.16 
DU - device utilization; BSI = bloodstream infection. 
*Number of CVC-days divided by the number of patient-days. 
fNumber of CVC-associated BSIs divided by the number of CVC-days and then multiplied by 
1.000. 
TABLE 5 
VENTILATOR UTILIZATION RATIO AND VENTILATOR-ASSOCIATED 
PNEUMONIA RATE ACCORDING TO BIRTH WEIGHT FOR SEVEN 
NEONATAL UNITS IN BRAZIL DURING 1997 TO 1998 
Birth 
Weight (g) 
No. of 
Patient-
Days 
No. of 
Ventilator-
Days 
DU 
Ratio* 
VAP 
Rate* 
=s 1,000 10,866 
1,001 to 1,500 15,936 
1,501 to 2,500 19,093 
> 2,500 14,153 
3,707 
2,286 
2,444 
2,057 
0.34 
0.14 
0.13 
0.15 
7.01 
9.19 
7.77 
8.26 
DU = device utilization; VAP = ventilator-associated pneumonia. 
*Number of ventilator-days divided by the number of patient-days. 
fNumber of VAPs divided by the number of ventilator-days and then multiplied by 1,000. 
higher device utilization rate for CVCs (P < .001). On the 
other hand, CVC use was statistically different among the 
other three groups, but the rates for CVC-associated BSI 
did not differ. Regarding ventilator-associated pneumonia, 
rates were similar for all groups, although device utiliza-
tion rates varied among the groups. 
DISCUSSION 
This is the first multicenter study and the largest 
study regarding healthcare-associated infection among 
neonates in Brazil. Incidence density rates for healthcare-
associated infection observed in this study were much 
higher than those observed in most studies in the United 
States or Europe,5'61215 but similar to those in another 
Brazilian study.16 On the other hand, few studies include 
healthcare-associated infection of maternal origin in the 
surveillance of healthcare-associated infection. In a large 
series in the United States, almost 12% of all healthcare-
associated infections were maternally acquired.9 In the 
current study, 28% of all healthcare-associated infections 
were of maternal origin. If only healthcare-associated 
infection of hospital origin had been considered for the 
calculation of rates, overall rates in this study would have 
been comparable to those in the previously mentioned 
studies from the United States and Europe. The unex-
pectedly high proportion of infections of maternal origin 
has also been documented by Kawagoe et al.,16 and may 
be a local phenomenon that deserves further evaluation. 
In addition, this study confirmed that neonates with a 
birth weight of 1,500 g or less were a high-risk population 
for healthcare-associated infection, as shown in other 
regions.6'17 
The distribution of sites was similar to that report-
ed by others9 but different from that for adults in intensive 
care units. BSI was the main healthcare-associated infec-
tion in all birth weight groups, accounting for 50% of all 
infections in this study. The high proportion of BSIs rep-
resented a major concern because they are associated 
with increased mortality, prolonged length of hospital 
stay, and slower growth among very low birth weight 
infants.18"20 
Rates of device-associated infections were extraor-
dinarily high when compared with National Nosocomial 
Infections Surveillance System data21 and should be a tar-
get of surveillance and prevention efforts. The use of 
devices such as CVCs and mechanical ventilators had 
already been identified as an independent risk factor for 
healthcare-associated infection in our milieu,16 and the 
infection control program in these units had already 
implemented specific guidelines for the prevention of 
device-related infections.2223 Regarding CVC-associated 
infections, greater device use was associated with a 
greater CVC-associated BSI rate, particularly among 
neonates weighing 1,000 g or less at birth. This finding 
may be due to a higher risk of BSI resulting from CVC use 
in this group. Surprisingly, greater ventilation use in the 
latter group was not associated with higher ventilator-
associated pneumonia rates, as compared with other birth 
weight groups. 
Among the pathogens responsible for healthcare-
associated infection of hospital origin, coagulase-negative 
staphylococci ranked first, similar to other reports.59 
Regarding the etiology of BSI, this pathogen comprised 
only 20.4% of the cases, whereas in other reports it was 
responsible for half of the cases.59 Conversely, enteric 
bacilli were the main pathogen of BSI in this series, and a 
similar etiology has been observed in the southern hemi-
sphere.1724 Group B Streptococcus was not detected with 
the same frequency as in the United States, but it was the 
main pathogen responsible for maternally acquired BSI. 
Such a finding is worrisome because this pathogen is fre-
quently underestimated in Brazil and no routine approach 
for prevention of perinatal group B streptococcal infection 
is currently recommended in this country. Five additional 
cases of group B streptococcal BSI occurred beyond 48 
hours after birth. The definitions applied in the current 
study did not take into account the pathogen, and the latter 
infections were classified as infections of hospital origin. 
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Pathogen identification was limited in this study. In 
particular, no regular surveillance for viral infections was 
conducted. Viruses may play an important role in gas-
trointestinal and eye, ear, nose, and throat infections.9 
Another shortcoming of the current study is that microbi-
ologic confirmation was relatively low, particularly for BSI 
of maternal origin. All of these units were provided with 
good laboratory support for bacteriologic identification, 
and laboratory constraints could not explain such a find-
ing. On the other hand, BSIs and pneumonia accounted 
for a high proportion of healthcare-associated infections, 
and the identification of etiologic agents may be difficult 
among neonates. In the current series, clinical sepsis 
accounted for most episodes of BSI, contrary to the 
results reported by Gaynes et al.9 We performed on-site 
surveillance of healthcare-associated infections with 
prospective follow-up of all admitted patients; this surveil-
lance strategy has been associated with a high sensitivity 
for BSI detection.25 Furthermore, although standard defi-
nitions were applied,8 these referred to clinical sepsis in 
patients younger than 1 year and not specifically to the 
neonatal period. In particular, neonates admitted to 
neonatal intensive care units are frequently unstable dur-
ing the first 48 hours after birth and their clinical mani-
festations make the differential diagnosis with non-infec-
tious syndromes difficult. Despite the prospective clinical 
follow-up, the employment of the aforementioned defini-
tions might have resulted in overestimation of BSIs in this 
series. These data suggest a compelling need for specific 
definitions for healthcare-associated infection during the 
neonatal period. 
We observed a high frequency of healthcare-associ-
ated infections of maternal origin. On the one hand, this 
might denote issues in perinatal care in Brazil. On the 
other hand, this might denote the need for specific defini-
tions for healthcare-associated infection during the neona-
tal period, especially during the first 48 hours after birth. 
Neonates weighing 1,500 g or less at birth and those who 
used a device were at increased risk for acquiring a 
healthcare-associated infection. These findings should be 
used to direct prevention and control efforts. 
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